Page last updated: 2024-10-29

ketamine and Dementia

ketamine has been researched along with Dementia in 8 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
" The current case report describes a patient suffering from severe depression and dementia who received electroconvulsive therapy with S-ketamine anesthesia at our psychiatric intensive care unit for the treatment of her therapy-resistant catatonic stupor."7.85Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia. ( Bauer, M; Frey, R; Kasper, S; Litvan, Z, 2017)
"Depression is a common psychiatric symptom in numerous neurological disorders."6.82(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression. ( Hashimoto, K; Wang, X; Yang, J, 2022)
" The current case report describes a patient suffering from severe depression and dementia who received electroconvulsive therapy with S-ketamine anesthesia at our psychiatric intensive care unit for the treatment of her therapy-resistant catatonic stupor."3.85Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia. ( Bauer, M; Frey, R; Kasper, S; Litvan, Z, 2017)
"Depression is a common psychiatric symptom in numerous neurological disorders."2.82(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression. ( Hashimoto, K; Wang, X; Yang, J, 2022)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (37.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Mielke, N1
Johnson, S1
Bahl, A1
Fadladdin, YAJ1
Xue, M1
Zhang, X1
Chen, J1
Liu, F1
Xu, J1
Xie, J1
Yang, Y1
Yu, W1
Qiu, H1
Xue, J1
Jiang, J1
Liu, Y2
Shallom, SJ1
Zelazny, AM1
Giri, AR1
Kaur, N1
Yarrarapu, SNS1
Rottman Pietrzak, KA1
Santos, C1
Lowman, PE1
Niaz, S1
Franco, PM1
Sanghavi, DK1
Zhu, D1
Liang, R1
Li, Z2
Cheng, L1
Ren, J1
Guo, Y1
Wang, M1
Chai, H1
Niu, Q1
Yang, S1
Bai, J1
Yu, H1
Zhang, H1
Qin, X1
Sahrakorpi, N1
Engberg, E1
Stach-Lempinen, B1
Tammelin, TH1
Kulmala, J1
Roine, RP1
Koivusalo, SB1
Cheng, W1
Pang, H1
Campen, MJ1
Zhang, J2
Li, Y1
Gao, J1
Ren, D1
Ji, X1
Rothman, N1
Lan, Q1
Zheng, Y1
Leng, S1
Hu, Z1
Tang, J1
Dong, Q1
Song, N1
Qin, N1
Chen, C1
Sun, X1
Easton, J1
Mulder, H1
Plyler, E1
Neale, G1
Walker, E1
Li, Q1
Ma, X1
Chen, X1
Huang, IC1
Yasui, Y1
Ness, KK1
Hudson, MM1
Robison, LL1
Wang, Z1
Subota, A1
Spotswood, N1
Roach, M1
Goodarzi, Z1
Holroyd-Leduc, J1
Park, EA1
Graves, SA1
Menda, Y1
Wang, X1
Yang, J1
Hashimoto, K1
Wu, S1
Ji, H1
Won, J1
Jo, EA1
Kim, YS1
Park, JJ1
Eldufani, J1
Nekoui, A1
Blaise, G1
Nanagas, K1
Avera, R1
Purpura, A1
Murphy, J1
Kao, L1
Litvan, Z1
Bauer, M1
Kasper, S1
Frey, R1
Ellison, G1
Yonou, H1
Kagawa, H1
Oda, A1
Nagano, M1
Gakiya, M1
Niimura, K1
Hatano, T1
Ogawa, Y1

Reviews

4 reviews available for ketamine and Dementia

ArticleYear
    Lancet regional health. Americas, 2022, Volume: 8

    Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mas

2022
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression.
    Neuroscience and biobehavioral reviews, 2022, Volume: 139

    Topics: Antidepressive Agents; Dementia; Depression; Humans; Ketamine; Nervous System Diseases; Stroke

2022
Nonanesthetic Effects of Ketamine: A Review Article.
    The American journal of medicine, 2018, Volume: 131, Issue:12

    Topics: Chronic Pain; Cognition; Dementia; Depression; Excitatory Amino Acid Antagonists; Humans; Ketamine

2018
The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.
    Brain research. Brain research reviews, 1995, Volume: 20, Issue:2

    Topics: Animals; Behavior, Animal; Dementia; Disease Models, Animal; Dizocilpine Maleate; Humans; Ketamine;

1995

Trials

1 trial available for ketamine and Dementia

ArticleYear
The Effects of Exergaming on Executive and Physical Functions in Older Adults With Dementia: Randomized Controlled Trial.
    Journal of medical Internet research, 2023, 03-07, Volume: 25

    Topics: Aged; Cognition; Cognitive Behavioral Therapy; Dementia; Exercise; Exergaming; Humans; Ketamine

2023

Other Studies

3 other studies available for ketamine and Dementia

ArticleYear
Articles You May Have Missed.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2018, Volume: 14, Issue:4

    Topics: Alcohol Withdrawal Delirium; Antidotes; Carbon Monoxide Poisoning; Chemical and Drug Induced Liver I

2018
Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia.
    International psychogeriatrics, 2017, Volume: 29, Issue:7

    Topics: Aged; Anesthesia; Catatonia; Dementia; Depressive Disorder, Major; Electroconvulsive Therapy; Female

2017
[Transurethral resection of the prostate for patients with dementia].
    Hinyokika kiyo. Acta urologica Japonica, 1999, Volume: 45, Issue:4

    Topics: Aged; Aged, 80 and over; Anesthesia, Spinal; Anesthetics, Dissociative; Anesthetics, Intravenous; De

1999